Mid-term efficacy & safety of CDA vs ACDF for 1-level cervical disc spondylosis
Mid-term efficacy & safety of CDA vs ACDF for 1-level cervical disc spondylosis
Effectiveness and safety of Mobi-C for treatment of single-level cervical disc spondylosis: a randomised control trial with a minimum of five years of follow-up
Bone Joint J. 2016 Jun;98-B(6):829-33Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
107 patients with single-level cervical spondylosis were randomized to undergo either cervical disc arthroplasty (CDA) with the Mobi-C Cervical Disc Prosthesis or ACDF. The purpose of this study was to compare patient-reported outcome measures, the radiographic range of motion of the index segment, and subsequent surgery rates between groups. At 5 year follow-up, no significant differences were ob...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.